Nucleic Acid Therapeutics
Mary Ann Liebert, Inc.
About the journal
Nucleic Acid Therapeutics is a journal published by Mary Ann Liebert, Inc. in United States. It is listed in MEDLINE according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Mary Ann Liebert, Inc.
- ISSN
- 2159-3337 · 2159-3345
- Country
- United States
- Access
- Not open access / not declared
Index listings
- MEDLINE · 2011-01-01
- Indexing
- MEDLINE
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
638
Last recorded publication year
2026
h-index
63
i10-index
391
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 92%
- ORCID iDs in current deposits
- 66%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Nucleic Acid Ther
- Source type
- journal
- NLM unique ID (PubMed)
- 101562758
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Advanced biosensing and bioanalysis techniques
- DNA and Nucleic Acid Chemistry
- DNA and Nucleic Acid Chemistry
- RNA and protein synthesis mechanisms
- RNA and protein synthesis mechanisms
Show all subjects (50)
- CRISPR and Genetic Engineering
- CRISPR and Genetic Engineering
- RNA Research and Splicing
- RNA Research and Splicing
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Virus-based gene therapy research
- Virus-based gene therapy research
- Muscle Physiology and Disorders
- Muscle Physiology and Disorders
- RNA modifications and cancer
- RNA modifications and cancer
- Neurogenetic and Muscular Disorders Research
- Neurogenetic and Muscular Disorders Research
- Immune Response and Inflammation
- Immune Response and Inflammation
- RNA regulation and disease
- RNA regulation and disease
- Immunotherapy and Immune Responses
- interferon and immune responses
- Immunotherapy and Immune Responses
- interferon and immune responses
- Genetic Neurodegenerative Diseases
- Genetic Neurodegenerative Diseases
- Bacteriophages and microbial interactions
- Bacteriophages and microbial interactions
- Viral Infections and Immunology Research
- Monoclonal and Polyclonal Antibodies Research
- Molecular Biology Techniques and Applications
- Molecular Biology Techniques and Applications
- Viral Infections and Immunology Research
- Monoclonal and Polyclonal Antibodies Research
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Cancer-related molecular mechanisms research
- Blood Coagulation and Thrombosis Mechanisms
- Cancer-related molecular mechanisms research
- Blood Coagulation and Thrombosis Mechanisms
- Retinal Development and Disorders
- Pluripotent Stem Cells Research
- Retinal Development and Disorders
- Pluripotent Stem Cells Research
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ